Exponent, Inc. (NASDAQ:EXPO – Get Free Report) Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the sale, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Exponent Stock Down 0.5 %
Shares of EXPO stock opened at $104.20 on Friday. Exponent, Inc. has a 12 month low of $68.70 and a 12 month high of $115.75. The company’s fifty day simple moving average is $107.71 and its 200-day simple moving average is $101.25. The firm has a market cap of $5.29 billion, a PE ratio of 50.34 and a beta of 0.69.
Exponent Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Friday, December 6th. Exponent’s dividend payout ratio is currently 54.11%.
Analyst Ratings Changes
Read Our Latest Stock Report on EXPO
Institutional Trading of Exponent
Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Exponent by 5.8% in the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after purchasing an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Exponent by 6.5% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock valued at $441,414,000 after buying an additional 284,179 shares during the last quarter. Conestoga Capital Advisors LLC grew its stake in shares of Exponent by 1.6% in the third quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock valued at $323,535,000 after buying an additional 43,257 shares in the last quarter. Geneva Capital Management LLC increased its holdings in Exponent by 1.7% during the third quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock worth $183,388,000 after buying an additional 27,339 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Exponent by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock worth $96,937,000 after acquiring an additional 6,108 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories
- Five stocks we like better than Exponent
- What is a support level?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Calculate Options Profits
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What is a Stock Market Index and How Do You Use Them?
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.